Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Norio, Hanafusa"'
Publikováno v:
Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-13 (2024)
Abstract Background In Japan dialyzers are classified as type I, II, III, IV, or V on the basis of the β 2-microglobulin clearance. In 2023, Type V dialyzers were defined as super high-flux membrane dialyzers. Herein, we investigate the association
Externí odkaz:
https://doaj.org/article/3f7590f19127499a99f9e232ac2e793b
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Dialyzers are classified into five types based on their β2-microglobulin clearance rate and albumin sieving coefficient: Ia, Ib, IIa, and IIb. In addition, a new classification system introduced a type S dialyzer. However, limited informati
Externí odkaz:
https://doaj.org/article/55283026b8d947c98271beff4d3e24c5
Autor:
Takafumi Yagisawa, Taichi Kanzawa, Yuya Fujiwara, Taro Banno, Ayaka Saito, Rikako Oki, Kohei Unagami, Toshihito Hirai, Kazuya Omoto, Norio Hanafusa, Hideki Ishida, Toshio Takagi
Publikováno v:
Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-6 (2024)
Abstract Background Plasmapheresis is an important preoperative desensitization treatment for ABO-incompatible living kidney transplantation. However, in cases with plasma exchange therapy (PET), it is necessary to consider the risks of perioperative
Externí odkaz:
https://doaj.org/article/788ec34250ae4777827380697e8f95e2
Publikováno v:
Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-14 (2024)
Abstract Background Approximately 16.4% of patients on hemodialysis (HD) in Japan are treated with intermittent infusion hemodiafiltration (I-HDF). However, large-scale data on clinical outcomes with this modality are lacking. This study aimed to com
Externí odkaz:
https://doaj.org/article/911a4e6b4992461bb0006f078f709e65
Autor:
Norio Hanafusa, Masanori Abe, Nobuhiko Joki, Junichi Hoshino, Kan Kikuchi, Shunsuke Goto, Eiichiro Kanda, Masatomo Taniguchi, Shigeru Nakai, Toshihide Naganuma, Takeshi Hasegawa, Kenichiro Miura, Atsushi Wada, Yoshiaki Takemoto, Japanese Society for Dialysis Therapy Renal Data Registry Committee
Publikováno v:
Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-31 (2024)
Abstract Background The 2020 Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) annual survey was sent to 4493 dialysis facilities in Japan. Methods Questionnaires were sent to all facilities that provide patients with dialysis therapy
Externí odkaz:
https://doaj.org/article/df926920438f4a109b58c7b52eaa90bb
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract In patients undergoing hemodialysis, the impact of atrial fibrillation (AF) through cardiac thromboembolism on the development of ischemic stroke may be influenced by the severity of atherosclerosis present. However, there are no large-scale
Externí odkaz:
https://doaj.org/article/176b9dbc19bf4b349c8fafa7e912a875
Autor:
Norio Hanafusa, Masanori Abe, Nobuhiko Joki, Tetsuya Ogawa, Eiichiro Kanda, Kan Kikuchi, Shunsuke Goto, Masatomo Taniguchi, Shigeru Nakai, Toshihide Naganuma, Takeshi Hasegawa, Junichi Hoshino, Kenichiro Miura, Atsushi Wada, Yoshiaki Takemoto, on behalf of Japanese Society for Dialysis Therapy Renal Data Registry Committee
Publikováno v:
Renal Replacement Therapy, Vol 9, Iss 1, Pp 1-37 (2023)
Abstract Background The Japanese Society for Dialysis Therapy is conducting the survey annually since 1968. The results provide a comprehensive picture of dialysis therapy in Japan. The survey for the year 2019 was performed as of December 2019. Meth
Externí odkaz:
https://doaj.org/article/19491d8f76d142e39e093641d0bbc10d
Publikováno v:
Renal Replacement Therapy, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Approximately 340,000 people in Japan are on chronic dialysis, and this number continues to increase. Even today, hemodialysis is the most frequently selected modality for renal replacement therapy in Japan, accounting for approximately 97%
Externí odkaz:
https://doaj.org/article/aa5a42333acb48549f096cbc52f75224
Autor:
Hirokazu Okada, Atsushi Ono, Koji Tomori, Tsutomu Inoue, Norio Hanafusa, Ken Sakai, Ichiei Narita, Toshiki Moriyama, Yoshitaka Isaka, Kei Fukami, Seiji Itano, Eiichiro Kanda, Naoki Kashihara
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0302101 (2024)
BackgroundInformation of short-term prognosis after hemodialysis (HD) introduction is important for elderly patients with chronic kidney disease (CKD) and their families choosing a modality of renal replacement therapy. Therefore, we developed a risk
Externí odkaz:
https://doaj.org/article/78ae097e03d54f368d48b45d8a6bdc58
Publikováno v:
Kidney and Dialysis, Vol 3, Iss 1, Pp 46-55 (2023)
Chronic kidney disease—mineral and bone disorder (CKD-MBD) is a systemic disorder that increases the risk of morbidity and mortality in dialysis patients. CKD-MBD is highly prevalent in dialysis patients, and appropriate treatment is important for
Externí odkaz:
https://doaj.org/article/5129d1affdae47f988fc4ae6078ecf6e